부산대학교 도서관

Azad AA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Prostate Cancer Theranostics and Imaging Centre of Excellence, Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. Electronic address: arun.azad@petermac.org.; Bressel M; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Tan H; Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, SA, Australia; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.; Voskoboynik M; Department of Medical Oncology, Alfred Health, Melbourne, VIC, Australia; School of Translational Medicine, Monash University, Melbourne, VIC, Australia.; Suder A; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.; Weickhardt AJ; Olivia Newton-John Cancer and Wellness Centre, Austin Health, Melbourne, VIC, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia.; Guminski A; Department of Medical Oncology, Royal North Shore Hospital, University of Sydney, Sydney, NSW, Australia.; Francis RJ; Department of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia; Medical School, University of Western Australia, Perth, WA, Australia.; Saghebi J; Prostate Cancer Theranostics and Imaging Centre of Excellence, Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Dhiantravan N; Department of Nuclear Medicine and Specialised PET Services, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.; Joshua AM; Department of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, NSW, Australia; Garvan Institute of Medical Research, Sydney, NSW, Australia.; Emmett L; Garvan Institute of Medical Research, Sydney, NSW, Australia; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital, Sydney, NSW, Australia; St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.; Horvath L; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, NSW, Australia; Central Clinical School, University of Sydney, Sydney, NSW, Australia.; Murphy DG; Prostate Cancer Theranostics and Imaging Centre of Excellence, Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Hsiao E; Department of Nuclear Medicine and PET, Royal North Shore Hospital, University of Sydney, Sydney, NSW, Australia.; Balakrishnar B; Department of Medical Oncology, Liverpool Hospital, Sydney, NSW, Australia.; Lin P; Department of Nuclear Medicine and PET, Liverpool Hospital, Sydney, NSW, Australia.; Redfern A; Medical School, University of Western Australia, Perth, WA, Australia; Department of Medical Oncology, Fiona Stanley Hospital, Perth, WA, Australia.; Macdonald W; Medical School, University of Western Australia, Perth, WA, Australia; Department of Nuclear Medicine, Fiona Stanley Hospital, Perth, WA, Australia.; Ng S; Department of Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia; Department of Oncology, University of Western Australia, Perth, WA, Australia.; Lee ST; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia; Department of Surgery, University of Melbourne, Melbourne, VIC, Australia; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia.; Pattison DA; Department of Nuclear Medicine and Specialised PET Services, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia; School of Medicine, University of Queensland, Brisbane, QLD, Australia.; Nadebaum D; Department of Nuclear Medicine and PET, Alfred Health, Melbourne, VIC, Australia.; Kirkwood ID; Department of Nuclear Medicine and PET, Royal Adelaide Hospital, Adelaide, SA, Australia; Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.; Hofman MS; Prostate Cancer Theranostics and Imaging Centre of Excellence, Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.

Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Eapen RS; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Electronic address: Renu.Eapen@petermac.org.; Buteau JP; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.; Jackson P; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Australia.; Mitchell C; Department of Anatomical Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Oon SF; Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia.; Alghazo O; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.; McIntosh L; Department of Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.; Dhiantravan N; Department of Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.; Scalzo MJ; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.; O'Brien J; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sandhu S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Azad AA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Williams SG; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sharma G; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Peter MacCallum Cancer Centre, Melbourne, Australia.; Haskali MB; Radiopharmaceutical Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.; Bressel M; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia.; Chen K; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.; Jenjitranant P; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.; McVey A; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Peter MacCallum Cancer Centre, Melbourne, Australia.; Moon D; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.; Lawrentschuk N; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.; Neeson PJ; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.; Hofman MS; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.

Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

Pathmanathan S; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Tariq A; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Pearce A; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Wesley Urology Clinic, The Wesley Hospital, Brisbane, Queensland, Australia.; Rhee H; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Department of Urology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Kyle S; Department of, Medical Imaging, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Raveenthiran S; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.; Department of Urology, Redcliffe Hospital, Brisbane, Queensland, Australia.; Wong D; I-MED Radiology, The Wesley Hospital, Brisbane, Queensland, Australia.; McBean R; I-MED Radiology, The Wesley Hospital, Brisbane, Queensland, Australia.; Marsh P; Department of Diagnostic Radiology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Goodman S; Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Dhiantravan N; Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Esler R; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.; Wesley Urology Clinic, The Wesley Hospital, Brisbane, Queensland, Australia.; Dunglison N; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Navaratnam A; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Yaxley J; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Wesley Urology Clinic, The Wesley Hospital, Brisbane, Queensland, Australia.; Thomas P; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Pattison DA; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Department of Nuclear Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Goh JC; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Gan CL; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Roberts MJ; Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029, Australia. m.roberts2@uq.edu.au.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia. m.roberts2@uq.edu.au.; Department of Urology, Redcliffe Hospital, Brisbane, Queensland, Australia. m.roberts2@uq.edu.au.; Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia. m.roberts2@uq.edu.au.

Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE

Hofman, M.S.; Sandhu, S.; Iravani, A.; Buteau, J.P.; Azad, A.A.; Williams, S.G.; Scott, A.M.; Lee, S.-T.; Emmett, L.; Joshua, A.M.; Lin, P.; Goh, J.C.; Pattison, D.A.; Martin, A.J.; Tan, T.H.; Kirkwood, I.D.; Ng, S.; Francis, R.J.; Redfern, A.D.; Macdonald, W.; Gedye, C.; Rutherford, N.K.; Weickhardt, A.; Kwan, E.M.; Ramdave, S.; Guminski, A.; Hsiao, E.; Chua, W.; Zhang, A.Y.; Stockler, M.R.; Davis, I.D.; Akhurst, T.; Alipour, R.; Bailey, D.; Banks, P.; Beaulieu, A.; Campbell, L.; Crumbaker, M.; Dhiantravan, N.; Hamid, A.; Haskali, M.; Hung, T.; Kong, G.; Lawrence, N.; Lewin, J.; McCarthy, M.; Moodie, K.; Murphy, D.; Nguyen, A.; Pook, D.; Ravi Kumar, A.; Roach, P.; Roselt, P.; Saghebi, J.; Schembri, G.; Spain, L.; Subramaniam, S.; Thang, S.P.; Thomas, P.; Tran, B.; Wallace, R.; Yip, S.

In: The Lancet Oncology. (The Lancet Oncology, January 2024, 25(1):99-107)

Shivde, R.; Marx, N.; Gacek, S.; Dhiantravan, S.; Balyasnikova, I.; Le Poole, I.

Journal of Investigative Dermatology; August 2024, Vol. 144 Issue: 8, Number 8 Supplement 1 pS111-S111, 1p

Su, Y.; Wanninger, N.; Dhiantravan, N.; Liang, J.; Dinda, P.; Campanoni, S.; Rainey, M.; Acar, U.A.

In: International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS, ASPLOS 2024 - Proceedings of the 29th ACM International Conference on Architectural Support for Programming Languages and Operating Systems. (International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS, 27 April 2024, 2:232-250)

Buteau, J.P.; Iravani, A.; Hofman, M.S.; Williams, S.G.; Sandhu, S.; Azad, A.A.; Scott, A.M.; Lee, S.-T.; Martin, A.J.; Zhang, A.Y.; Stockler, M.R.; Emmett, L.; Joshua, A.M.; Francis, R.J.; McJannett, M.M.; Davis, I.D.; Akhurst, T.; Alipour, R.; Banks, P.; Beaulieu, A.; Chua, W.; Dhiantravan, N.; Ford, K.; Gedye, C.; Goh, J.C.; Guminski, A.; Hamid, A.; Haskali, M.B.; Hicks, R.J.; Hsiao, E.; Kirkwood, I.D.; Kong, G.; Kwan, E.M.; Langford, A.; Lawrence, N.; Lewin, J.; Lin, P.; McDonald, W.; Moodie, K.; Murphy, D.G.; Ng, S.; Pattison, D.A.; Pokorski, I.; Ramdave, S.; Ravi Kumar, A.S.; Redfern, A.D.; Rutherford, N.K.; Saghebi, J.; Spain, L.; Subramaniam, S.; Tan, T.H.; Thang, S.P.; Tran, B.; Wallace, R.; Weickhardt, A.; Yip, S.

In: The Lancet Oncology. (The Lancet Oncology, November 2022, 23(11):1389-1397)

Dhiantravan N; Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Emmett L; Department of Theranostics, St Vincent's Hospital, Sydney, NSW, Australia.; Garvan Institute of Medical Research, Sydney, NSW, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Sydney, NSW, Australia.; Joshua AM; Garvan Institute of Medical Research, Sydney, NSW, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Sydney, NSW, Australia.; Department of Medical Oncology, The Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, NSW, Australia.; Pattison DA; Department of Nuclear Medicine & Specialised PET Services, Royal Brisbane & Women's Hospital, Brisbane, QLD, Australia.; School of Medicine, University of Queensland, Brisbane, QLD, Australia.; Francis RJ; Department of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia.; Medical School, University of Western Australia, Perth, WA, Australia.; The Australasian Radiopharmaceutical Trial network (ARTnet), Sydney, NSW, Australia.; Williams S; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Sydney, NSW, Australia.; Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sandhu S; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Sydney, NSW, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Davis ID; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Sydney, NSW, Australia.; Eastern Health, Melbourne, VIC, Australia.; Eastern Health Clinical School, Monash University, Melbourne, VIC, Australia.; Vela I; Department of Urology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia.; Prostate Cancer Research Centre-Queensland, Translational Research Institute, Queensland University of Technology, Brisbane, QLD, Australia.; Neha N; Centre for Biostatistics and Clinical Trials (BaCT), Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Bressel M; Centre for Biostatistics and Clinical Trials (BaCT), Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Murphy DG; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Hofman MS; Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Sydney, NSW, Australia.; Azad AA; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Sydney, NSW, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-410X (Electronic) Linking ISSN: 14644096 NLM ISO Abbreviation: BJU Int Subsets: MEDLINE

Bagguley D; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, 3000, Australia.; EJ Whitten Prostate Cancer Research Centre at Epworth, Melbourne, 3121, Australia.; Ong S; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, 3000, Australia.; EJ Whitten Prostate Cancer Research Centre at Epworth, Melbourne, 3121, Australia.; Buteau JP; Molecular Imaging & Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, 3000, Australia.; Koschel S; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, 3000, Australia.; Dhiantravan N; Molecular Imaging & Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, 3000, Australia.; Hofman MS; Molecular Imaging & Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, 3000, Australia.; Emmett L; St Vincent's Hospital Nuclear Medicine & PET Department, Darlinghurst, 2010, Australia.; Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, 3000, Australia.; Lawrentschuk N; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, 3000, Australia.; EJ Whitten Prostate Cancer Research Centre at Epworth, Melbourne, 3121, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, 3000, Australia.; Department of Urology, Royal Melbourne Hospital, Parkville, 3000, Australia.; Department of Surgery, University of Melbourne, Austin Hospital, Heidelberg, 3084, Australia.

Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

MCGEORGE, S. T. E. P. H. E. N.; JIANG, A. N. D. R. E. W.; PATTISON, D. A. V. I. D.; DHIANTRAVAN, N. A. T. T. A. K. O. R. N.; THOMAS, P. A. U. L.; YAXLEY, J. O. H. N.; ROBERTS, M. A. T. T. H. E. W.

BJU INTERNATIONAL; JUN 2022, 129 p59-p60, 2p. Supplement: 2